No abstract available
MeSH terms
-
Accreditation
-
Australia
-
Cost-Benefit Analysis
-
Diffusion of Innovation
-
Fluorodeoxyglucose F18 / supply & distribution
-
Humans
-
Neoplasms / diagnostic imaging*
-
Radiopharmaceuticals / supply & distribution
-
Tomography, Emission-Computed* / economics
-
Tomography, Emission-Computed* / instrumentation
-
Tomography, Emission-Computed* / standards
Substances
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18